Denis Dekugmen Yar1, Samson Pandam Salifu1,2, Samuel Nkansah Darko1, Augustina Angelina Annan1, Akosua Adumea Gyimah3, Kwame Ohene Buabeng4, Ellis Owusu-Dabo1,5. 1. Kumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. 2. Department of Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. 3. Ghana Health Service, Kumasi South Hospital, Ashanti Region, Ghana. 4. Department of Clinical and Social Pharmacy, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. 5. School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Abstract
OBJECTIVES: The objective of this study is to describe the burden of human papillomavirus (HPV) infection among women living with HIV and non-infected women in Ghana. METHODS: A case-control study was conducted involving 107 women living with HIV aged between 18 and 59 years (cases) and 100 non-HIV-infected apparently healthy women (controls) who were recruited from the Kumasi South Hospital, from July to December, 2014. Cervicovaginal swabs were taken from study participants to characterise 28 high- and low-risk HPV genotypes using a multiplex real-time PCR. RESULTS: The overall mean age for the participants was 40.10 ± 9.76 years. The prevalence of high-risk (hr)-HPV genotypes was significantly higher among the cases than the controls (77.4% vs. 41.6%, P < 0.0001). Overall, HPV 58 and 54 were the most predominant high-risk (18.8%) and low-risk (15.0%) genotypes detected. The two most common hr-HPV genotype isolates were 58 (18.8%) and 35 (15.9%) with 58 being the most prevalent among age group 35-44 years compared with hr-HPV 16, 18, 35 and 45, found predominantly among 18-34 age group. CONCLUSIONS: Significant variations exist in HPV genotypes among HIV-infected and uninfected women.
OBJECTIVES: The objective of this study is to describe the burden of human papillomavirus (HPV) infection among women living with HIV and non-infected women in Ghana. METHODS: A case-control study was conducted involving 107 women living with HIV aged between 18 and 59 years (cases) and 100 non-HIV-infected apparently healthy women (controls) who were recruited from the Kumasi South Hospital, from July to December, 2014. Cervicovaginal swabs were taken from study participants to characterise 28 high- and low-risk HPV genotypes using a multiplex real-time PCR. RESULTS: The overall mean age for the participants was 40.10 ± 9.76 years. The prevalence of high-risk (hr)-HPV genotypes was significantly higher among the cases than the controls (77.4% vs. 41.6%, P < 0.0001). Overall, HPV 58 and 54 were the most predominant high-risk (18.8%) and low-risk (15.0%) genotypes detected. The two most common hr-HPV genotype isolates were 58 (18.8%) and 35 (15.9%) with 58 being the most prevalent among age group 35-44 years compared with hr-HPV 16, 18, 35 and 45, found predominantly among 18-34 age group. CONCLUSIONS: Significant variations exist in HPV genotypes among HIV-infected and uninfected women.
Authors: Emmanuel T Donkoh; Richard H Asmah; Francis Agyemang-Yeboah; Ellis O Dabo; Edwin K Wiredu Journal: Cancer Control Date: 2022 Jan-Dec Impact factor: 2.339
Authors: Marco H Schulze; Fabian M Völker; Raimond Lugert; Paul Cooper; Kai Hasenclever; Uwe Groß; Herbert Pfister; Steffi Silling Journal: Med Microbiol Immunol Date: 2016-09-06 Impact factor: 3.402
Authors: Amrei Krings; Priscilla Dunyo; Aleksandra Pesic; Saviour Tetteh; Benjamin Hansen; Isaac Gedzah; Comfort M Wormenor; Joseph E Amuah; Anna-Lisa Behnke; Daniela Höfler; Michael Pawlita; Andreas M Kaufmann Journal: PLoS One Date: 2019-06-27 Impact factor: 3.240
Authors: Oksana Debrah; Francis Agyemang-Yeboah; Emmanuel Timmy Donkoh; Richard Harry Asmah Journal: BMC Womens Health Date: 2021-10-26 Impact factor: 2.809